Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0	6.25	79.11	15.96
Revenue Growth (YoY)	-	-	-92.09%	395.55%	7.83%
Gross Profit	0	0	6.25	79.11	15.96
Selling, General & Admin	22.91	24.13	28.78	37.06	32.92
Research & Development	48.9	69.98	68.52	106.82	85.76
Other Operating Expenses	0	0	41.64	0	0
Operating Expenses	71.81	94.11	138.94	143.88	118.68
Operating Income	-71.81	-94.11	-132.69	-64.78	-102.71
Other Expense / Income	-10.61	-1.02	-0.3	-2.62	-4.31
Pretax Income	-61.2	-93.09	-132.39	-62.15	-98.41
Income Tax	0.03	0	-2.53	0	-0.77
Net Income	-61.23	-93.09	-129.86	-62.15	-97.63
Shares Outstanding (Basic)	5	4	4	3	2
Shares Outstanding (Diluted)	5	4	4	3	2
Shares Change	13.47%	11.85%	22.17%	34.92%	15.16%
EPS (Basic)	-13.38	-23.08	-36.00	-21.00	-44.64
EPS (Diluted)	-13.38	-23.08	-36.00	-21.00	-44.64
Free Cash Flow	22.51	-84.57	-95.64	-63.43	-85.62
Free Cash Flow Per Share	4.92	-20.96	-26.52	-21.48	-39.13
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-2121.65%	-81.89%	-643.44%
Profit Margin	-	-	-2076.35%	-78.57%	-611.63%
Free Cash Flow Margin	-	-	-1529.18%	-80.18%	-536.37%
EBITDA	-60.75	-92.59	-131.92	-61.46	-97.91
EBITDA Margin	-	-	-2109.37%	-77.70%	-613.38%
Depreciation & Amortization	0.45	0.5	0.47	0.69	0.49
EBIT	-61.2	-93.09	-132.39	-62.15	-98.41
EBIT Margin	-	-	-2116.82%	-78.57%	-616.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).